Axogen, Inc. Appoints John H. Johnson to Board of Directors
19 juil. 2021 16h01 HE
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., July 19, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to...
Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021
14 juil. 2021 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., July 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...
Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference
18 mai 2021 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to...
Axogen, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
06 mai 2021 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla. , May 06, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity...
Axogen, Inc. Reports 2021 First Quarter Financial Results
05 mai 2021 16h00 HE
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
Axogen, Inc. to Report First Quarter Financial Results and Host Conference Call on May 5, 2021
14 avr. 2021 07h00 HE
|
Axogen, Inc.
ALACHUA Fla. and TAMPA, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...
Axogen, Inc. Promotes Peter J. Mariani to Executive Vice President and Chief Financial Officer
01 mars 2021 16h01 HE
|
Axogen, Inc.
ALACHUA, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
Axogen, Inc. Reports 2020 Fourth Quarter and Full-Year Financial Results
22 févr. 2021 16h01 HE
|
Axogen, Inc.
ALACHUA, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis
18 févr. 2021 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
Axogen, Inc. to Participate at Upcoming February Investor Conferences
04 févr. 2021 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...